真性中出 真性中出 ,色色男 色色男 ,成仁网站 成仁网站

发布日期:2021年10月16日

PMC Organometallix Continues Expansion

Wednesday, 09 December 2020 真性中出 真性中出 ,色色男 色色男 ,成仁网站 成仁网站 by Corporate
Mount Laurel, NJ (December 9, 2020) PMC Organometallix Inc., a wholly owned subsidiary of PMC Group N.A., Inc. is pleased to confirm that, despite challenges presented by the global pandemic, it has embarked on, and will continue with plans to expand capacity for production of organotin intermediates at Axis, AL and for organotin catalysts at

PMC Biogenix Announces Price Increase on Certain Product Lines

Monday, 16 November 2020 by Corporate真性中出 真性中出 ,色色男 色色男 ,成仁网站 成仁网站
MEMPHIS, TN (November 13, 2020) — PMC Biogenix Inc. announces that effective December 1, 2020 or as otherwise consistent with current written contracts, prices for products sold under the trademarks Armoslip®, Hystrene®, Industrene®, Kemamide®, Kemester®, and Lubrazinc® will be increased by 5 – 15% depending upon grade. Customers with questions should contact their sales manager for
Mount Laurel, NJ (January 2, 2020) — PMC Group N.A., Inc. (“PMC”) and Lanxess Organometallics GmbH (“Lanxess”) have announced that PMC has acquired Lanxess’ organotin specialties product line (the “Business”). The transaction, previously reported on November 13, 2019, has closed effective December 30, 2019. The Business included Lanxess’ global organotin catalyst, organotin specialties and intermediates product
真性中出 真性中出 ,色色男 色色男 ,成仁网站 成仁网站
MOUNT LAUREL, NJ (November 13, 2019) — PMC Group N.A., Inc. (“PMC”) and Lanxess Organometallics GmbH are pleased to announce that the parties have reached an agreement whereby PMC’s European subsidiary will acquire the organotin specialties product line (the “Business”) from Lanxess. The transaction is scheduled to close by year end, subject to customary closing
Read more 真性中出 真性中出 ,色色男 色色男 ,成仁网站 成仁网站
TOP